Cardiac Rhythm Management Devices Market is set to grow at a CAGR of around 6.5% by 2026, fueled by technological advancements and increasing user base: says Absolute Markets Insights


Cardiac Rhythm Management Devices (CRMDs) primarily include pacemakers and defibrillators, which are implanted to monitor heart rhythm and activity of patients. Cardiac rhythm management is an interventional method that enables physicians to study the causes of irregular heartbeats, which is essential in determining the appropriate method of treatment. This data is also used in learning patterns and predicting outcomes.

 

“The implantable cardiac rhythm management segment is growing notably. In coming future, the cardiac rhythm management devices market would witness adoption of systems that collect the related useful information and send it to the concerned doctor or health consultant automatically.”

 Among various device types, the defibrillator segment significantly contributes to the overall market revenue. In terms of regions, North America and Europe together, account for around 60% of the overall cardiac rhythm management devices market revenue. The Asia Pacific region presently contributes 18% to the overall revenue and has witnessed a notable growth in the recent past.

Cardiac Rhythm Management Devices Market

The detailed research study provides qualitative and quantitative analysis of the cardiac rhythm management devices market. The market has been analyzed from demand as well as supply side. The demand side analysis covers market revenue as well as sales volume across regions and further, across all the major countries. The supply side analysis covers regional production volume and capacity analysis. The geographical analysis done emphasizes on each of the major countries across North America, Europe, Asia Pacific, Middle East and Africa and Latin America.

The competitive analysis conducted narrates that the cardiac rhythm management devices market is composed of several players. Some of the prominent competitors include Siemens AG, 3M Company(3M), Abiomed, Inc.(ABIOMED), Berlin Heart GmbH (Berlin Heart), Biotronik SE & Co. KG, Boston Scientific Corporation, Cardiac Science Corporation, General Electric Company (General Electric), Hill-Rom Services Inc., Jarvik Heart, Inc., Koninklijke Philips N.V., LivaNova PLC, Medtronic, NIHON KOHDEN CORPORATION, and ZOLL Medical Corporation among others. Lifevest is a wearable defibrillator that is being increasingly utilized by patients at risk for sudden cardiac arrest. It is a popular product manufactured by Asahi Kasei Corporation, which is a company based in Tokyo, Japan. Powerheart G5 is an AED designed by Cardiac Science, which is a company headquartered in Waukesha, Wisconsin, United States. It is a product known for an eight year warranty that is amongst the longest duration in this industry.

Cardiac Rhythm Management Devices Market - by Product 

  • Pacemakers
    • Implantable Pacemakers
    • External Pacemakers
  • Defibrillators
    • Implantable Cardioverter Defibrillators (ICDs)
      • Subcutaneous ICD (S-ICD)
      • Transvenous ICD (T-ICD)
    • External Defibrillator (ED)
      • Manual ED
      • Automated ED (AED)
      • Wearable Cardioverter Defibrillator
  • Cardiac Resynchronization Therapy (CRT)
    • CRT Defibrillators (CRT-D)
    • CRT Pacemakers (CRT-P)

Cardiac Rhythm Management Devices Market - by End User 

  • Hospitals and Clinics
  • Home Settings
  • Ambulatory Service Centers

Cardiac Rhythm Management Devices Market – by Region

  • North America
    • U.S.
    • Rest of North America
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
    • Rest of Asia Pacific
  • Middle East and Africa
    • GCC Countries
    • Southern Africa
    • Rest of Middle East and Africa
  • Latin America
    • Brazil
    • Rest of Latin America